Growth factors, antagonists and lung cancer.
作者信息
Woll P J
出版信息
J R Soc Med. 1993 Nov;86(11):621-2.
Abstract
摘要
相似文献
1
Growth factors, antagonists and lung cancer.
J R Soc Med. 1993 Nov;86(11):621-2.
2
New perspectives in lung cancer. 2. Growth factors and lung cancer.
Thorax. 1991 Dec;46(12):924-9. doi: 10.1136/thx.46.12.924.
3
[Treatment of lung cancer].
Orv Hetil. 2010 Mar 28;151(13):552-3. doi: 10.1556/OH.2010.28841.
4
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.
Thorax. 1999 Feb;54(2):169-79. doi: 10.1136/thx.54.2.169.
5
Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy.
Anticancer Res. 1997 Sep-Oct;17(5B):3777-80.
6
The role of targeting mammalian target of rapamycin in lung cancer.
Clin Lung Cancer. 2008 Nov;9(6):340-5. doi: 10.3816/CLC.2008.n.049.
7
A high molecular weight non-bombesin/gastrin releasing peptide growth factor in small cell lung cancer.
Br J Cancer. 1987 Dec;56(6):791-4. doi: 10.1038/bjc.1987.290.
8
Progress in understanding the molecular pathogenesis of human lung cancer.
Biochim Biophys Acta. 1998 Aug 19;1378(1):F21-59. doi: 10.1016/s0304-419x(98)00010-9.
9
Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy.
J Cancer Res Clin Oncol. 2000 Jun;126(6):352-6. doi: 10.1007/s004320050355.
10
Small cell lung cancer: biological and therapeutic aspects.
Crit Rev Oncol Hematol. 1996 Jan;22(1):27-60. doi: 10.1016/1040-8428(94)00170-7.
本文引用的文献
1
Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.
Proc Natl Acad Sci U S A. 1983 May;80(10):2936-40. doi: 10.1073/pnas.80.10.2936.
2
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Nature. 1985;316(6031):823-6. doi: 10.1038/316823a0.
3
[Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
Biochem Biophys Res Commun. 1988 Aug 30;155(1):359-65. doi: 10.1016/s0006-291x(88)81093-3.
4
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
J Clin Invest. 1988 Jul;82(1):354-9. doi: 10.1172/JCI113594.
5
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
Eur J Pharmacol. 1989 Mar 21;162(2):273-80. doi: 10.1016/0014-2999(89)90290-2.
6
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.
J Clin Oncol. 1989 Oct;7(10):1398-406. doi: 10.1200/JCO.1989.7.10.1398.
7
Beta-endorphin and neurotensin stimulate in vitro clonal growth of human SCLC cells.
Eur J Pharmacol. 1989 Feb 28;161(2-3):283-5. doi: 10.1016/0014-2999(89)90862-5.
8
Multiple neuropeptides mobilise calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin.
Biochem Biophys Res Commun. 1989 Oct 16;164(1):66-73. doi: 10.1016/0006-291x(89)91683-5.
9
Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung.
Cancer Res. 1990 Nov 1;50(21):7077-80.
10
[Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Cancer Res. 1991 Apr 1;51(7):1798-802.
Zotero 插件